Status:
COMPLETED
Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Coronary Artery Disease
Cardiopulmonary Bypass
Eligibility:
All Genders
18-80 years
Brief Summary
Cardiopulmonary bypass (CPB) is known to alter pharmacokinetics (PK) and brain sensitivity to several drugs, including propofol. Few studies, however, have tested if propofol pharmacokinetical alterat...
Eligibility Criteria
Inclusion
- Isolated coronary artery bypass indication
- Left ventricular ejection fraction greater than 50 %
- Absence of preoperative pulmonary dysfunction
Exclusion
- Intra and postoperative circulatory shock
- Postoperative pulmonary dysfunction
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00622791
Last Update
February 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05403000